Get my own profile
Public access
View all35 articles
4 articles
available
not available
Based on funding mandates
Co-authors
Mikhail SavitskiEMBLVerified email at embl.de
Gerard DrewesCellzome/GlaxoSmithKline R&DVerified email at gsk.com
Bernhard KusterProfessor for Proteomics and BioanalyticsVerified email at tum.de
Isabelle BecherEMBL HeidelbergVerified email at embl.de
Nico ZinnCellzome GmbH, a GSK companyVerified email at gsk.com
Wolfgang HuberEMBL - European Molecular Biology LaboratoryVerified email at embl.org
Nils KurzawaCellzome, a GSK companyVerified email at gsk.com
Michael O. GlockerProteome Center RostockVerified email at med.uni-rostock.de
Mathias WilhelmComputational Mass Spectrometry, Technical University of MunichVerified email at tum.de
Hannes HahneOmicScouts GmbHVerified email at omicscouts.com
Friedrich ReinhardVP Academic Partnerships, Evotec International GmbHVerified email at evotec.com
Markus SchirleNovartis Institutes for BioMedical ResearchVerified email at novartis.com
Rab PrinjhaGlaxoSmithklineVerified email at gsk.com
Yann AbrahamJanssen Pharmaceutical Companies of Johnson & JohnsonVerified email at its.jnj.com
Hans-Juergen ThiesenProfessor of Immunology,University RostockVerified email at med.uni-rostock.de
Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
Par NordlundKarolinska InstitutetVerified email at ki.se
Daniel Martinez MolinaCSO at Pelago Bioscience, SwedenVerified email at pelagobio.com
Fiona PachlAstraZenecaVerified email at astrazeneca.com
Arjen ScholtenPrincipal Scientist Analytical Development; Janssen Vaccines & PreventionVerified email at its.jnj.com